Ceritinib

Contraindicated

Ceritinib Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Ceritinib Simvastatin Flolipid Explained Increased simvastatin exposure and an increased the risk of myopathy and rhabdomyolysis Details Ceritinib Dihydroergotamine Injection DHE-45® Injection Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Ceritinib Dihydroergotamine Nasal Spray Migranal Increased dihydroergotamine exposure and an increased risk of dihydroergotamine-related adverse effects Details Ceritinib Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Ceritinib Ivabradine Corlanor Increased ivabradine exposure, an increased risk of ivabradine-related adverse effects and an increased risk of QT prolongation Details Ceritinib Ketoconazole Topical Extina® Foam Increased ceritinib exposure, increased ketoconazole exposure and an increased risk of QT interval prolongation Details Ceritinib Lefamulin Xenleta Increased lefamulin exposure, an increased risk of lefamulin-related adverse reactions, an increased sensitive CYP3A4 substrate ex... Details Ceritinib Lovastatin Altocor® Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Ceritinib Lurasidone Latuda Increased lurasidone exposure Details Ceritinib Naloxegol Movantik Increased naloxegol exposure and an increased risk of naloxegol-related adverse effects Details

Major

Ceritinib Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Ceritinib Clindamycin ANTIROBE Explained Increased exposure of CYP3A substrate Details Ceritinib Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Ceritinib Sertraline Explained An increased risk of QT interval prolongation Details Ceritinib Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure and an increased risk of buprenorphine-related adv... Details Ceritinib Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Ceritinib Abemaciclib Verzenio Explained Increased exposure of CYP3A substrate Details Ceritinib Acalabrutinib Calquence Increased exposure of CYP3A substrate Details Ceritinib Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Ceritinib Apixaban Eliquis Explained Increased CYP3A substrate exposure Details Ceritinib Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Ceritinib Aripiprazole Injection Abilify Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Details Ceritinib Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Ceritinib Asciminib Scemblix Increased asciminib exposure, increased CYP3A4 substrate exposure, increased risk of asciminib-related adverse effects and an incr... Details Ceritinib Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Ceritinib Atenolol Tenormin Explained Increased risk of bradycardia Details Ceritinib Atogepant Qulipta Increased atogepant exposure Details Ceritinib Avapritinib Ayvakit Increased avapritinib exposure and increased incidence and severity of adverse reactions Details Ceritinib Azithromycin AzaSite An increased risk of QT interval prolongation Details Ceritinib Acebutolol Sectral® Increased risk of bradycardia Details Ceritinib Atorvastatin Atorvaliq Increased CYP3A substrate exposure Details Ceritinib Cariprazine Vraylar Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Ceritinib Alfuzosin UroXatral An increased risk of QT interval prolongation Details Ceritinib Amlodipine Amvaz® Increased CYP3A substrate exposure Details Ceritinib Anagrelide Agrylin An increased risk of QT interval prolongation Details Ceritinib Axitinib Inlyta Increased exposure of CYP3A substrate Details Ceritinib Azilsartan Edarbi Increased exposure of CYP2C9 substrate Details Ceritinib Beclomethasone Nasal Spray Beconase Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details Ceritinib Beclomethasone Oral Inhalation Beclovent® Increased beclomethasone exposure and an increased risk of beclomethasone-related adverse reactions Details